WP
Woodline Partners Portfolio holdings
AUM
$18.9B
1-Year Return
23.37%
This Quarter Return
-0.99%
1 Year Return
+23.37%
3 Year Return
+125.78%
5 Year Return
+185.63%
10 Year Return
–
AUM
$10.4B
AUM Growth
-$393M
(-3.6%)
Cap. Flow
-$94.4M
Cap. Flow
% of AUM
-0.9%
Top 10 Holdings %
Top 10 Hldgs %
14.8%
Holding
711
New
186
Increased
182
Reduced
155
Closed
168
Top Buys
| 1 |
Marsh & McLennan
MMC
|
$123M |
| 2 |
Electronic Arts
EA
|
$102M |
| 3 |
Chord Energy
CHRD
|
$100M |
| 4 |
Quest Diagnostics
DGX
|
$89.2M |
| 5 |
Sensata Technologies
ST
|
$73.8M |
Top Sells
| 1 |
Analog Devices
ADI
|
$138M |
| 2 |
Avnet
AVT
|
$131M |
| 3 |
ERF
Enerplus Corporation
ERF
|
$110M |
| 4 |
PXD
Pioneer Natural Resource Co.
PXD
|
$73.5M |
| 5 |
Amazon
AMZN
|
$73.3M |
Sector Composition
| 1 | Healthcare | 42.62% |
| 2 | Technology | 19.87% |
| 3 | Energy | 7.88% |
| 4 | Industrials | 7.25% |
| 5 | Financials | 7.06% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
251
Globus Medical
GMED
$8.04B
| $9.49M | 0.09% |
+138,528
| New | +$9.49M |
|
252
Viatris
VTRS
$12.2B
| $9.46M | 0.09% |
889,500
| – | – |
|
253
Jasper Therapeutics
JSPR
$43.1M
| $9.4M | 0.09% |
413,940
+34,694
| +9% | +$788K |
|
254
Immunocore
IMCR
$1.85B
| $9.29M | 0.09% |
274,038
| – | – |
|
255
NewAmsterdam Pharma
NAMS
$2.83B
| $9.29M | 0.09% |
+483,388
| New | +$9.29M |
|
256
Olema Pharmaceuticals
OLMA
$520M
| $9.22M | 0.09% |
852,554
+102,275
| +14% | +$1.11M |
|
257
Crown Holdings
CCK
$10.9B
| $9.18M | 0.09% |
123,350
-172,287
| -58% | -$12.8M |
|
258
Silicon Laboratories
SLAB
$4.42B
| $9.06M | 0.09% |
+81,886
| New | +$9.06M |
|
259
BioNTech
BNTX
$24.7B
| $9.04M | 0.09% |
112,538
+57,803
| +106% | +$4.65M |
|
260
Larimar Therapeutics
LRMR
$336M
| $9.01M | 0.09% |
1,242,585
+92,252
| +8% | +$669K |
|
261
Frontier Communications
FYBR
$9.34B
| $8.9M | 0.08% |
+339,832
| New | +$8.9M |
|
262
Graco
GGG
$14.2B
| $8.84M | 0.08% |
+111,534
| New | +$8.84M |
|
|
SLRN
263
DELISTED
ACELYRIN
SLRN
| $8.75M | 0.08% |
1,984,810
+963,606
| +94% | +$4.25M |
|
264
Chewy
CHWY
$17.2B
| $8.69M | 0.08% |
+318,889
| New | +$8.69M |
|
|
RCM
265
DELISTED
R1 RCM Inc. Common Stock
RCM
| $8.68M | 0.08% |
691,442
+81,220
| +13% | +$1.02M |
|
266
D.R. Horton
DHI
$54.9B
| $8.66M | 0.08% |
+61,468
| New | +$8.66M |
|
267
W.W. Grainger
GWW
$47.7B
| $8.61M | 0.08% |
+9,547
| New | +$8.61M |
|
268
Elanco Animal Health
ELAN
$9.46B
| $8.59M | 0.08% |
+594,979
| New | +$8.59M |
|
269
Union Pacific
UNP
$129B
| $8.53M | 0.08% |
37,706
-72,207
| -66% | -$16.3M |
|
270
RadNet
RDNT
$5.54B
| $8.46M | 0.08% |
143,612
-54,097
| -27% | -$3.19M |
|
271
Walt Disney
DIS
$214B
| $8.44M | 0.08% |
84,974
-51,847
| -38% | -$5.15M |
|
272
Amneal Pharmaceuticals
AMRX
$3.06B
| $8.35M | 0.08% |
1,315,023
+626,917
| +91% | +$3.98M |
|
273
Toll Brothers
TOL
$14.3B
| $8.33M | 0.08% |
+72,302
| New | +$8.33M |
|
274
Amcor
AMCR
$18.9B
| $8.24M | 0.08% |
+842,257
| New | +$8.24M |
|
275
Phathom Pharmaceuticals
PHAT
$882M
| $8.1M | 0.08% |
785,990
+219,551
| +39% | +$2.26M |
|